{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:19:50Z","timestamp":1784546390890,"version":"3.55.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2024LCYXZX30"],"award-info":[{"award-number":["2024LCYXZX30"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116631","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:43:36Z","timestamp":1775900616000},"page":"116631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Revisiting CCL22 in autoimmune diseases: pathogenesis and clinical implications"],"prefix":"10.1016","volume":"179","author":[{"given":"ZiXian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HanXiao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhangRong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuanMin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.intimp.2026.116631_bb0005","article-title":"Autoimmune disease","volume":"18","year":"2000","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116631_bb0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/90935","article-title":"Autoimmune disease: why and where it occurs","volume":"7","author":"Marrack","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.116631_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116631_bb0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines--chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.116631_bb0025","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm1196-1174","article-title":"Chemokine receptors: gateways to inflammation and infection","volume":"2","author":"Premack","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.116631_bb0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.iy.12.040194.003113","article-title":"The molecular biology of leukocyte chemoattractant receptors","volume":"12","author":"Murphy","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116631_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116631_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1238541","article-title":"CCL22-specific t cells: modulating the immunosuppressive tumor microenvironment","volume":"5","author":"Martinenaite","year":"2016","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0045","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory t cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.116631_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101055","article-title":"Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase \u03b1 (DGK\u03b1)\/NOX4 axis","volume":"73","author":"Chen","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0055","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.185.9.1595","article-title":"Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells","volume":"185","author":"Godiska","year":"1997","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jlb.64.1.49","article-title":"Profile of human macrophage transcripts: insights into macrophage biology and identification of novel chemokines","volume":"64","author":"Chantry","year":"1998","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0065","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1189\/jlb.68.3.400","article-title":"Macrophage-derived chemokine (MDC)","volume":"68","author":"Mantovani","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"7852","key":"10.1016\/j.intimp.2026.116631_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-021-03239-2","article-title":"Affinity-coupled CCL22 promotes positive selection in germinal centres","volume":"592","author":"Liu","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2026.116631_bb0075","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20070081","article-title":"Altering the distribution of foxp3(+) regulatory t cells results in tissue-specific inflammatory disease","volume":"204","author":"Sather","year":"2007","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1 t helper cells (th1s) and th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0085","doi-asserted-by":"crossref","first-page":"2115655","DOI":"10.1080\/2162402X.2022.2115655","article-title":"CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment","volume":"11","author":"Lecoq","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000015000","article-title":"Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13","volume":"81","author":"Nomiyama","year":"1998","journal-title":"Cytogenet. Cell Genet."},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.188.3.451","article-title":"Activated murine b lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated t cells","volume":"188","author":"Schaniel","year":"1998","journal-title":"J. Exp. Med."},{"issue":"17","key":"10.1016\/j.intimp.2026.116631_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713083","article-title":"Macrophage-derived chemokine MDC\/CCL22: an ambiguous finding in COVID-19","volume":"24","author":"Korobova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.intimp.2026.116631_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215542","article-title":"CCR4 as a therapeutic target for cancer immunotherapy","volume":"13","author":"Yoshie","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0110","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","article-title":"Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4","volume":"273","author":"Imai","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010381","article-title":"Chemokines in cartilage regeneration and degradation: new insights","volume":"25","author":"Edderkaoui","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.116631_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112306","article-title":"The C-C chemokines CCL17 and CCL22 and their receptor CCR4 in CNS autoimmunity","volume":"18","author":"Scheu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.116631_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084232","article-title":"Systematic assessment of chemokine signaling at chemokine receptors CCR4, CCR7 and CCR10","volume":"22","author":"Lim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116631_bb0130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1165\/rcmb.2017-0240OC","article-title":"\u0392-Arrestin-2-dependent signaling promotes CCR4-mediated chemotaxis of murine T-helper type 2 cells","volume":"58","author":"Lin","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"100","key":"10.1016\/j.intimp.2026.116631_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2014.02.007","article-title":"Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists","volume":"729","author":"Ajram","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/eji.200324429","article-title":"Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human th2 cells","volume":"34","author":"Mariani","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"55","key":"10.1016\/j.intimp.2026.116631_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe2749","article-title":"Persistence of mature dendritic cells, T(H)2A, and tc2 cells characterize clinically resolved atopic dermatitis under IL-4R\u03b1 blockade","volume":"6","author":"Bangert","year":"2021","journal-title":"Sci. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0150","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ni.f.212","article-title":"Interstitial leukocyte migration and immune function","volume":"9","author":"Friedl","year":"2008","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116631_bb0155","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/acsptsci.4c00330","article-title":"Exploring an intracellular allosteric site of CC-chemokine receptor 4 from 3D models, probe simulations, and mutagenesis","volume":"7","author":"Ding","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116631_bb0160","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1084\/jem.20170277","article-title":"CCL22 controls immunity by promoting regulatory t cell communication with dendritic cells in lymph nodes","volume":"216","author":"Rapp","year":"2019","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: from bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"Int. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116631_bb0170","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","article-title":"The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory t cells bear functional skin-homing receptors","volume":"177","author":"Hirahara","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0175","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1189\/jlb.0305139","article-title":"Induction of surface CCR4 and its functionality in mouse th2 cells is regulated differently during th2 development","volume":"78","author":"Morimoto","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9440(10)64378-7","article-title":"Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes","volume":"160","author":"Kunkel","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0185","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1084\/jem.20130091","article-title":"Lung dendritic cells imprint t cell lung homing and promote lung immunity through the chemokine receptor CCR4","volume":"210","author":"Mikhak","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.116631_bb0190","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue tregs","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116631_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/JLB.2AB0520-275R","article-title":"Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22","volume":"109","author":"Meyrath","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116631_bb0200","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/annrheumdis-2013-204228","article-title":"Regulatory t cells in rheumatoid arthritis showed increased plasticity toward th17 but retained suppressive function in peripheral blood","volume":"74","author":"Wang","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0205","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41598-018-37894-9","article-title":"A transcription factor PU.1 is critical for ccl22 gene expression in dendritic cells and macrophages","volume":"9","author":"Yashiro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116631_bb0210","doi-asserted-by":"crossref","first-page":"1092767","DOI":"10.3389\/fphar.2023.1092767","article-title":"Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116631_bb0215","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/art.42097","article-title":"Self-assembled human skin equivalents model macrophage activation of cutaneous fibrogenesis in systemic sclerosis","volume":"74","author":"Huang","year":"2022","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0220","volume":"12","author":"Chiu","year":"2023","journal-title":"Emerging Microbes & Infections"},{"issue":"2","key":"10.1016\/j.intimp.2026.116631_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1615\/CritRevImmunol.v22.i2.10","article-title":"Regulation of macrophage-derived chemokine (MDC, CCL22) production","volume":"22","author":"Yamashita","year":"2002","journal-title":"Crit. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0230","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory t helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2026.116631_bb0235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1186\/s12967-025-06911-7","article-title":"GM-CSF potentiates macrophages to retain an inflammatory feature from their circulating monocyte precursors in rheumatoid arthritis","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116631_bb0245","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.4049\/jimmunol.1202307","article-title":"CCL22-producing CD8\u03b1- myeloid dendritic cells mediate regulatory t cell recruitment in response to G-CSF treatment","volume":"191","author":"Layseca-Espinosa","year":"2013","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0250","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI87828","article-title":"Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation","volume":"126","author":"Achuthan","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2026.116631_bb0255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2006.08.004","article-title":"Macrophage-derived chemokine (MDC)\/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis","volume":"44","author":"Hashimoto","year":"2006","journal-title":"J. Dermatol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0260","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1175794","article-title":"Cancer cell-derived IL-1\u03b1 induces CCL22 and the recruitment of regulatory t cells","volume":"5","author":"Wiedemann","year":"2016","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.intimp.2026.116631_bb0265","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.molcel.2012.05.011","article-title":"Cell-type-specific control of enhancer activity by H3K9 trimethylation","volume":"46","author":"Zhu","year":"2012","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.intimp.2026.116631_bb0270","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1039\/C4FO00322E","article-title":"Sesamin suppresses macrophage-derived chemokine expression in human monocytes via epigenetic regulation","volume":"5","author":"Hsieh","year":"2014","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2026.116631_bb0275","doi-asserted-by":"crossref","first-page":"1654717","DOI":"10.3389\/fimmu.2025.1654717","article-title":"The chemokines CCL22 and CCL17 are a defining feature of type 2 stimulated human lung macrophages and exhibit different metabolic dependencies","volume":"16","author":"Ridley","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116631_bb0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2172-3-7","article-title":"IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype","volume":"3","author":"Loke","year":"2002","journal-title":"BMC Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116631_bb0285","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2017.11.043","article-title":"Blocking interleukin (IL)4- and IL13-mediated phosphorylation of STAT6 (tyr641) decreases m2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer","volume":"100","author":"Rahal","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.intimp.2026.116631_bb0290","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ol.2021.12644","article-title":"Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4\/STAT6 in the tumor microenvironment","volume":"21","author":"Kimura","year":"2021","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.intimp.2026.116631_bb0295","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1002\/1521-4141(200212)32:12<3506::AID-IMMU3506>3.0.CO;2-#","article-title":"Skin-homing CLA+ t cells and regulatory CD25+ t cells represent major subsets of human peripheral blood memory t cells migrating in response to CCL1\/I-309","volume":"32","author":"Colantonio","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116631_bb0300","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0305","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional t cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116631_bb0310","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/jid.2015.26","article-title":"CCL22 to activate treg migration and suppress depigmentation in vitiligo","volume":"135","author":"Eby","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116631_bb0315","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory t cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116631_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116631_bb0325","doi-asserted-by":"crossref","first-page":"1444964","DOI":"10.3389\/fimmu.2024.1444964","article-title":"Macrophage polarization and its impact on idiopathic pulmonary fibrosis","volume":"15","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrendo.2009.275","article-title":"Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?","volume":"6","author":"Chatenoud","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116631_bb0335","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI43048","article-title":"Prevention of murine autoimmune diabetes by CCL22-mediated treg recruitment to the pancreatic islets","volume":"121","author":"Montane","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.intimp.2026.116631_bb0340","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.4049\/jimmunol.1400567","article-title":"Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes","volume":"194","author":"Bischoff","year":"2015","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116631_bb0345","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s00125-017-4419-8","article-title":"Multipeptide-coupled nanoparticles induce tolerance in \u2018humanised\u2019 HLA-transgenic mice and inhibit diabetogenic CD8(+) t cell responses in type 1 diabetes","volume":"60","author":"Xu","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.intimp.2026.116631_bb0350","first-page":"367","article-title":"Genetic polymorphisms of CCL22 and CCR4 in patients with lung cancer, Iran","volume":"39","author":"Erfani","year":"2014","journal-title":"J. Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0355","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13075-018-1759-9","article-title":"The effect of the cholinergic anti-inflammatory pathway on collagen-induced arthritis involves the modulation of dendritic cell differentiation","volume":"20","author":"Liu","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2009.10.005","article-title":"Expression of MDC\/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis","volume":"49","author":"Flytlie","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2026.116631_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109010","article-title":"Peptidyl arginine deiminase expression and macrophage polarization following stimulation with citrullinated and malondialdehyde-acetaldehyde modified fibrinogen","volume":"110","author":"Aripova","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116631_bb0370","doi-asserted-by":"crossref","first-page":"1556359","DOI":"10.3389\/fcell.2025.1556359","article-title":"Resolution of inflammation during rheumatoid arthritis","volume":"13","author":"Ye","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0375","first-page":"267","article-title":"Study on ratio imbalance of peripheral blood Th17\/Treg cells in patients with rheumatoid arthritis","volume":"26","author":"Niu","year":"2010","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"12","key":"10.1016\/j.intimp.2026.116631_bb0380","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.autrev.2012.02.019","article-title":"Functional niche of inflamed synovium for th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics","volume":"11","author":"Dong","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2026.116631_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109814","article-title":"Negative impact of interleukin-9 on synovial regulatory t cells in rheumatoid arthritis","volume":"257","author":"Chakraborty","year":"2023","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0390","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12016-007-0045-4","article-title":"Cellular aspects of atopic dermatitis","volume":"33","author":"Ou","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0395","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjd.18652","article-title":"Atopic dermatitis in the elderly: a review of clinical and pathophysiological hallmarks","volume":"182","author":"Williamson","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"14","key":"10.1016\/j.intimp.2026.116631_bb0400","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2217\/imt-2022-0054","article-title":"Immunotherapy in atopic dermatitis","volume":"14","author":"Li","year":"2022","journal-title":"Immunotherapy"},{"issue":"11","key":"10.1016\/j.intimp.2026.116631_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026987","article-title":"Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies","volume":"6","author":"Hirota","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2026.116631_bb0410","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","article-title":"Biomarkers in atopic dermatitis-a review on behalf of the international eczema council","volume":"147","author":"Renert-Yuval","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0415","doi-asserted-by":"crossref","first-page":"23054","DOI":"10.1038\/s41598-024-73244-8","article-title":"Identification of novel hub genes and immune infiltration in atopic dermatitis using integrated bioinformatics analysis","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116631_bb0420","doi-asserted-by":"crossref","first-page":"9370893","DOI":"10.1155\/2016\/9370893","article-title":"Inhibitory effect of valencene on the development of atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"2016","author":"Yang","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2026.116631_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105676","article-title":"Anti-inflammatory effects of quercetin in a mouse model of MC903-induced atopic dermatitis","volume":"74","author":"Hou","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0430","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4049\/jimmunol.179.1.673","article-title":"Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"179","author":"Laborde","year":"2007","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2026.116631_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213829","article-title":"Multiplex analysis of serum cytokine profiles in systemic lupus erythematosus and multiple sclerosis","volume":"23","author":"Melamud","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10238-025-01790-0","article-title":"CCL22 as a diagnostic and prognostic biomarker for pediatric-onset systemic lupus erythematosus","volume":"25","author":"Chen","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.116631_bb0445","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00296-010-1499-x","article-title":"Anti-macrophage-derived chemokine antibody relieves murine lupus nephritis","volume":"31","author":"Liu","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2026.116631_bb0450","doi-asserted-by":"crossref","first-page":"6012715","DOI":"10.1155\/2016\/6012715","article-title":"Chemokines and chemokine receptors in the development of lupus nephritis","volume":"2016","author":"Liao","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.intimp.2026.116631_bb0455","first-page":"1205","article-title":"Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci","volume":"26","author":"Molineros","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.intimp.2026.116631_bb0460","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0002-9440(10)63903-X","article-title":"Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis","volume":"162","author":"Garcia","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116631_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291772","article-title":"Integrated analysis of phase 1a and 1b randomized controlled trials; treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors","volume":"18","author":"Fujikawa","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2026.116631_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003731","article-title":"Anti-CCR4 treatment depletes regulatory t cells and leads to clinical activity in a canine model of advanced prostate cancer","volume":"10","author":"Maeda","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2026.116631_bb0475","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.jid.2018.06.186","article-title":"HSP70i(Q435A)-encoding DNA repigments vitiligo lesions in Sinclair swine","volume":"138","author":"Henning","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000487","article-title":"Th1 is the predominant helper t cell subset that produces GM-CSF in the joint of rheumatoid arthritis","volume":"3","author":"Yamada","year":"2017","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.intimp.2026.116631_bb0485","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrrheum.2009.178","article-title":"G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis","volume":"5","author":"Cornish","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116631_bb0490","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis","volume":"145","author":"He","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116631_bb0495","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1399-3038.2007.00692.x","article-title":"Serum levels of th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis","volume":"19","author":"Nakazato","year":"2008","journal-title":"Pediatr. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116631_bb0500","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/eji.201646387","article-title":"Mapping urinary chemokines in human lupus nephritis: potentially redundant pathways recruit CD4(+) and CD8(+) t cells and macrophages","volume":"47","author":"Klocke","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116631_bb0505","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1093\/rheumatology\/kead551","article-title":"Inflammatory arthritis complicating mogamulizumab treatment of s\u00e9zary syndrome","volume":"63","author":"Bass","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2026.116631_bb0510","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/all.15949","article-title":"Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: a phase 1 study","volume":"79","author":"Bissonnette","year":"2024","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.intimp.2026.116631_bb0515","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:06:47Z","timestamp":1777129607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926004765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":103,"alternative-id":["S1567576926004765"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116631","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting CCL22 in autoimmune diseases: pathogenesis and clinical implications","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116631"}}